These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25762364)

  • 41. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.
    Bergman PJ; McKnight J; Novosad A; Charney S; Farrelly J; Craft D; Wulderk M; Jeffers Y; Sadelain M; Hohenhaus AE; Segal N; Gregor P; Engelhorn M; Riviere I; Houghton AN; Wolchok JD
    Clin Cancer Res; 2003 Apr; 9(4):1284-90. PubMed ID: 12684396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.
    Giacobino D; Camerino M; Riccardo F; Cavallo F; Tarone L; Martano M; Dentini A; Iussich S; Lardone E; Franci P; Valazza A; Manassero L; Del Magno S; De Maria R; Morello E; Buracco P
    Vet Comp Oncol; 2021 Dec; 19(4):651-660. PubMed ID: 33751759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma.
    Spugnini EP; Dragonetti E; Vincenzi B; Onori N; Citro G; Baldi A
    Melanoma Res; 2006 Feb; 16(1):23-7. PubMed ID: 16432452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GM-CSF plus antigenic peptide vaccination in locally advanced melanoma patients.
    Atzpodien J; Reitz M
    Cancer Biother Radiopharm; 2007 Aug; 22(4):551-5. PubMed ID: 17803450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.
    Slingluff CL; Yamshchikov G; Neese P; Galavotti H; Eastham S; Engelhard VH; Kittlesen D; Deacon D; Hibbitts S; Grosh WW; Petroni G; Cohen R; Wiernasz C; Patterson JW; Conway BP; Ross WG
    Clin Cancer Res; 2001 Oct; 7(10):3012-24. PubMed ID: 11595689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
    Soiffer R; Hodi FS; Haluska F; Jung K; Gillessen S; Singer S; Tanabe K; Duda R; Mentzer S; Jaklitsch M; Bueno R; Clift S; Hardy S; Neuberg D; Mulligan R; Webb I; Mihm M; Dranoff G
    J Clin Oncol; 2003 Sep; 21(17):3343-50. PubMed ID: 12947071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suicide gene therapy on spontaneous canine melanoma: correlations between in vivo tumors and their derived multicell spheroids in vitro.
    Gil-Cardeza ML; Villaverde MS; Fiszman GL; Altamirano NA; Cwirenbaum RA; Glikin GC; Finocchiaro LM
    Gene Ther; 2010 Jan; 17(1):26-36. PubMed ID: 19741734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of locoregional metastases of malignant melanomas with radiotherapy and intralesional beta-interferon injection.
    Paul E; Müller I; Renner H; Bödeker RH; Cochran AJ
    Melanoma Res; 2003 Dec; 13(6):611-7. PubMed ID: 14646625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice.
    Zhang TY; Huang B; Wu HB; Wu JH; Li LM; Li YX; Hu YL; Han M; Shen YQ; Tabata Y; Gao JQ
    J Control Release; 2015 Jul; 209():260-71. PubMed ID: 25966361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of Acemannan Immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas.
    King GK; Yates KM; Greenlee PG; Pierce KR; Ford CR; McAnalley BH; Tizard IR
    J Am Anim Hosp Assoc; 1995; 31(5):439-47. PubMed ID: 8542364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant therapy of melanoma.
    Spitler LE
    Oncology (Williston Park); 2002 Jan; 16(1 Suppl 1):40-8. PubMed ID: 11829281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial.
    Elias EG; Zapas JL; McCarron EC; Beam SL; Hasskamp JH; Culpepper WJ
    Cancer Biother Radiopharm; 2008 Jun; 23(3):285-91. PubMed ID: 18593361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of the melanoma vaccine in 38 dogs: The South African experience.
    McLean JL; Lobetti RG
    J S Afr Vet Assoc; 2015 Apr; 86(1):1246. PubMed ID: 26016668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction.
    ; Celis E
    Cancer; 2007 Jul; 110(1):203-14. PubMed ID: 17541944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs.
    Hogge GS; Burkholder JK; Culp J; Albertini MR; Dubielzig RR; Yang NS; MacEwen EG
    Cancer Gene Ther; 1999; 6(1):26-36. PubMed ID: 10078961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokine-enhanced vaccine and suicide gene therapy as adjuvant treatments of metastatic melanoma in a horse.
    Finocchiaro LM; Riveros MD; Glikin GC
    Vet Rec; 2009 Feb; 164(9):278-9. PubMed ID: 19252217
    [No Abstract]   [Full Text] [Related]  

  • 58. Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group.
    Sondak VK; Liu PY; Tuthill RJ; Kempf RA; Unger JM; Sosman JA; Thompson JA; Weiss GR; Redman BG; Jakowatz JG; Noyes RD; Flaherty LE
    J Clin Oncol; 2002 Apr; 20(8):2058-66. PubMed ID: 11956266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma.
    Dillman RO; Nayak SK; Barth NM; DeLeon C; Schwartzberg LS; Spitler LE; Church C; O'Connor AA; Beutel LD
    Cancer Biother Radiopharm; 1998 Jun; 13(3):165-76. PubMed ID: 10850352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma.
    Milevoj N; Tratar UL; Nemec A; Brožič A; Žnidar K; Serša G; Čemažar M; Tozon N
    Res Vet Sci; 2019 Feb; 122():40-49. PubMed ID: 30453179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.